|
|
Clinical practice guidelines on liver transplantation for hepatocellular carcinoma in China (2018 edition) |
Xiao Xu a , ∗, Jun Chen a , Qiang Wei a , Zhi-Kun Liu a , Zhe Yang a , Ming Zhang b , Guo-Ying Wang c , Jie Gao d , Zhao-Xu Yang e , Wen-Yuan Guo f , Tong-Hai Xing g , Zhou Shao a , Qin-Fen Xie h , Shu-Sen Zheng a , ∗ |
a Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
b Department of Liver Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
c Department of Hepatic Surgery, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China
d Department of Hepatobiliary Surgery, Peking University People’s Hospital, Beijing 100044, China
e Department of Hepatobiliary Surgery, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
f Department of Liver Surgery and Organ Transplantation, Changzheng Hospital, Naval Medical University, Shanghai 200003, China
g General Surgery Center, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200080, China
h Department of Hepatobiliary and Pancreatic Surgery, Shulan (Hangzhou) Hospital, Hangzhou 310004, China
∗ Corresponding authors.
E-mail addresses: zjxu@zju.edu.cn (X. Xu), zyzss@zju.edu.cn (S.-S. Zheng).
|
|
|
Abstract Over 3 00 000 people in China die each year of hepatocellular carcinoma (HCC), which accounts for approximately half of HCC- related deaths worldwide. Liver transplantation (LT) is generally recognized as one of the most effective therapeutic approaches for end-stage liver diseases. Since the beginning of the second LT boom in the 1990s, LT in China has been developed rapidly with professional and large-scale trends, and it is approaching or has reached the level of developed countries in terms of quantity and quality. According to the China Liver Transplant Registry, the num- ber of transplants for HCC accounted for 36.8% of the total number of LT cases during the past 5 years in the mainland of China. In or- der to develop an effective, safe and standardized protocol to guide the national LT practice, the clinical guidelines of LT for HCC was launched in 2014 by multidisciplinary experts from Chinese Society of Organ Transplantation, Chinese Medical Association and Chinese Association of Organ Transplantation, Chinese Medical Doctor As- sociation. Recently, there have been new clinical and scientific ad- vances in the field of LT and to keep abreast of these achievements, the original clinical practice guidelines need to be updated.
|
|
|
|
|
|
|
|